Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
TCRT holding history
Alaunos Therapeutics, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TCRT overviewAll 13F holders of TCRTFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −11−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q2 2024 | 105 | $73 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 105 | $190 | <0.1% | −1−0.8% | ReducedConverted for a 1-for-15 split | Holders |
| Q4 2023 | 1,587 | $112 | <0.1% | −179−10.1% | Reduced | Holders |
| Q3 2023 | 1,766 | $233 | <0.1% | +1,766 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −53,320−100.0% | Sold out | Holders |
| Q4 2022 | 53,320 | $34.6K | <0.1% | −98,050−64.8% | Reduced | Holders |
| Q3 2022 | 151,370 | $260.0K | <0.1% | +7,345+5.1% | Added | Holders |
| Q2 2022 | 144,025 | $179.0K | <0.1% | +144,025 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −379,766−100.0% | Sold out | Holders |
| Q4 2021 | 379,766 | $414.0K | <0.1% | +379,766 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −48,099−100.0% | Sold out | Holders |
| Q2 2021 | 48,099 | $127.0K | <0.1% | +48,099 | New | Holders |